Chodakewitz Jeffrey — SEC Form 4 filings
SEC reporting owner CIK 1610876. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-06 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adicet Bio, Inc. (ACET) | Director | 4 | — | — | 13 |
| Schrodinger, Inc. (SDGR) | Director | 3 | — | — | 6 |
| Praxis Precision Medicines, Inc. (PRAX) | Director | 3 | — | — | 4 |
Form 4 filings — Chodakewitz Jeffrey
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Adicet Bio, Inc. (ACET) | Grant/award (A): 4,200 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 1,371 @ $0 · Grant/award (A): 648 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 10,520 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Adicet Bio, Inc. (ACET) | Grant/award (A): 5,900 @ $0 · Grant/award (A): 26,400 (derivative) @ $0 | EDGAR |
| 2024-08-23 | 4 | Adicet Bio, Inc. (ACET) | Disposition to issuer (D): 30,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 · Disposition to issuer (D): 18,500 (derivative) @ $0 · Grant/award (A): 18,500 (derivative) @ $0 · Disposition to issuer (D): 18,500 (derivative) @ $0 · Grant/award (A): 18,500 (derivative) @ $0 · +2 more | EDGAR |
| 2024-06-20 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 5,000 @ $0 · Grant/award (A): 8,550 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Adicet Bio, Inc. (ACET) | Grant/award (A): 5,900 @ $0 · Grant/award (A): 26,400 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 8,566 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1610876 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →